Results 121 to 127 of about 1,393 (127)

Recommendations for the use of sapropterin in phenylketonuria

Molecular Genetics and Metabolism, 2012
Elaina Jurecki, Renee Shediac, Jane Gillis   +2 more
exaly  

Sapropterin dihydrochloride for phenylketonuria and tetrahydrobiopterin deficiency

Expert Review of Endocrinology and Metabolism, 2010
Nenad Blau
exaly  

Long-term developmental progression in infants and young children taking sapropterin for phenylketonuria: a two-year analysis of safety and efficacy

Genetics in Medicine, 2015
Nicola Longo, Komudi Siriwardena, Annette Feigenbaum   +2 more
exaly  

International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria

Molecular Genetics and Metabolism, 2019
Ania C Muntau, Amaya Bélanger-Quintana, Yin-Hsiu Chien   +2 more
exaly  

Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU)

Molecular Genetics and Metabolism, 2010
Barbara K Burton, Holly Laduca, Christine Sullivan   +2 more
exaly  

Optimizing the use of sapropterin (BH4) in the management of phenylketonuria

Molecular Genetics and Metabolism, 2009
Nenad Blau, Amaya Bélanger-Quintana, Mubeccel Demirkol   +2 more
exaly  

Is sapropterin treatment suitable for all subjects with phenylketonuria?

Expert Opinion on Pharmacotherapy, 2008
exaly